Danish Cohort Will Track Why Diabetic Foot Ulcers Fail to Heal
Diabetic foot ulcers remain one of the most stubborn complications of diabetes, and the burden is large enough to make even modest gains in wound healing clinically meaningful. In Denmark, as in much of the world, diabetes has risen sharply over recent decades, and the risk of a foot ulcer across a patient’s lifetime is substantial. A diabetic foot ulcer is rarely just a skin defect; it is the visible endpoint of neuropathy, altered biomechanics, tissue ischemia, repetitive trauma and delayed repair, all converging on the same wound bed.
A Danish multicentre prospective cohort study is designed to examine a question that matters at the bedside: how do physical activity and adherence to prescribed footwear influence the healing of diabetic foot ulcers? The protocol is built around objective measurement rather than patient recollection alone, using repeated wound area assessments alongside objective registration of physical activity and footwear use. That design reflects a practical clinical problem. Patients may understand the advice to reduce load on the foot, but real-world behavior often diverges from instructions once pain is absent, daily routines intervene, or the footwear itself feels cumbersome.
The study is not testing an intervention in the randomized-trial sense. It is observing what happens over time in routine care, which means it can describe patterns with precision but cannot claim cause and effect. Even so, a cohort that captures several data points per participant over 16 weeks has the potential to map the relationship between daily ambulation, adherence to protective footwear and wound trajectory with unusual clarity.
Why Offloading and Adherence Remain Central to Ulcer Healing
For clinicians who manage diabetic foot disease, the biological logic is straightforward. Repetitive pressure and shear on an insensate foot keep breaking down fragile tissue, while inadequate offloading allows a wound to reopen after each step. Protective footwear is meant to redistribute pressure and protect the ulcerated area, but its benefit depends on actual use, not prescription alone. A shoe that sits beside the bed cannot unload a plantar wound.
This is where objective adherence measurement becomes especially valuable. Existing literature has struggled to capture how often patients truly wear prescribed footwear, and that gap limits interpretation of many healing studies. A patient may report good adherence while still spending long stretches barefoot at home or wearing the protective shoe inconsistently. If wound healing stalls, the distinction between treatment failure and treatment nonadherence becomes clinically important, because the remedy is completely different.
The protocol’s emphasis on physical activity adds another layer. Activity is not inherently harmful in diabetes; mobility supports cardiovascular health, glucose control and independence. Yet for an open foot ulcer, each step can also be a mechanical challenge to tissue repair. The interaction between activity level and footwear adherence may therefore matter more than either variable alone. A patient who walks frequently but wears the offloading device consistently may behave very differently from a patient who is equally active but intermittently unprotected.
Objective Measurement May Clarify a Common Bedside Paradox
The study’s strengths are rooted in measurement discipline. Wound area will be tracked objectively, and both activity and adherence will be captured with direct registration rather than estimated from memory. Multiple data points over 16 weeks should allow investigators to evaluate healing patterns across time rather than rely on a single baseline and endpoint snapshot. In chronic wound care, serial measurement often tells a more truthful story than a one-time impression at the clinic visit.
There is also a practical reason this matters. The clinical course of a diabetic foot ulcer is often nonlinear. A wound may appear stable for a period, then improve after a change in loading, or worsen after a short period of increased walking. By capturing repeated observations, the cohort design can examine whether changes in behavior precede changes in wound size, even though it cannot prove that one caused the other. In a condition where minor alterations in pressure can influence tissue breakdown, temporal resolution is not a luxury.
The protocol also draws a clear boundary around generalisability. Patients using custom footwear are excluded, which narrows the population and means the findings will not automatically apply to every person with a diabetic foot ulcer. Custom devices often represent a different clinical subgroup with unique biomechanics and severity patterns. Excluding them may reduce heterogeneity, but it also limits how broadly the results can be applied in everyday practice.
A Study Designed to Inform Real-World Wound Care
The epidemiology behind the protocol explains why the question deserves attention. Diabetes affected about 830 million people globally in 2022, compared with 200 million in 1990, and the lifetime risk of developing a diabetic foot ulcer is estimated at 19% to 34%. Once a ulcer develops, healing can be painfully slow. A recent meta-analysis found that about 70% of diabetic foot ulcers remained unhealed after 20 weeks. Those figures frame the clinical urgency behind a study that focuses on modifiable behavior rather than biology alone.
What makes this protocol especially relevant is its focus on behaviors that are already part of standard care. Patients are routinely told to reduce pressure, protect the foot and wear prescribed footwear. Yet clinicians still struggle to determine why some ulcers close while others persist. The answer may lie not in the prescription itself, but in the degree to which the prescribed offloading strategy fits into actual daily life.
If the cohort confirms that higher activity or poorer footwear adherence tracks with slower wound closure, the implications would be immediate for counseling, monitoring and perhaps the design of future adherence-support tools. If the relationship is weaker than expected, that finding would also matter, because it would push attention toward other drivers of nonhealing such as perfusion, infection burden, neuropathy severity or patient-specific biomechanics. Either result would help refine the way clinicians interpret a chronic wound that refuses to improve.
The real value of the Danish study lies in its refusal to treat adherence as an abstract concept. In diabetic foot care, the wound heals or it does not, and the difference may depend on how much pressure reaches the ulcerated tissue during ordinary life. This protocol is built to measure that reality with more precision than self-report ever can.